1739 related articles for article (PubMed ID: 9632891)
21. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen.
Milich DR; Jones JE; McLachlan A; Bitter G; Moriarty A; Hughes JL
J Immunol; 1990 May; 144(9):3544-51. PubMed ID: 1691763
[TBL] [Abstract][Full Text] [Related]
22. [Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. II. Combined analysis of immunogenicity of composite peptides in rabbits].
Isaruliants MG; Ruden U; Wahren B
Biokhimiia; 1996 Jul; 61(7):1230-40. PubMed ID: 9035736
[TBL] [Abstract][Full Text] [Related]
23. Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen.
Lobaina Y; Palenzuela D; Pichardo D; Muzio V; Guillén G; Aguilar JC
Mol Immunol; 2005 Feb; 42(3):289-94. PubMed ID: 15589316
[TBL] [Abstract][Full Text] [Related]
24. The immune response to hepatitis B virus.
Waters JA; Pignatelli M; Brown D; O'Rourke S; Lever A; Thomas HC
Postgrad Med J; 1987; 63 Suppl 2():51-6. PubMed ID: 2446303
[TBL] [Abstract][Full Text] [Related]
25. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
[TBL] [Abstract][Full Text] [Related]
26. [Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH
Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
[TBL] [Abstract][Full Text] [Related]
27. [Enhancement of immune responses of hepatitis B virus core DNA vaccine by a signal Peptide and a universal helper T lymphocyte epitope].
Zhao P; Zhao LJ; Cao J; Hong HY; Qi ZT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 May; 34(3):341-6. PubMed ID: 12019449
[TBL] [Abstract][Full Text] [Related]
28. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
29. Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines.
Nassal M; Skamel C; Vogel M; Kratz PA; Stehle T; Wallich R; Simon MM
Int J Med Microbiol; 2008 Jan; 298(1-2):135-42. PubMed ID: 17888729
[TBL] [Abstract][Full Text] [Related]
30. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
[TBL] [Abstract][Full Text] [Related]
31. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
Lazdina U; Cao T; Steinbergs J; Alheim M; Pumpens P; Peterson DL; Milich DR; Leroux-Roels G; Sällberg M
J Virol; 2001 Jul; 75(14):6367-74. PubMed ID: 11413303
[TBL] [Abstract][Full Text] [Related]
32. [Humoral and cellular immunogenecity of genetic vaccine on core gene of hepatitis B virus in mice].
Huang Z; Lu S; Liu N
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):456-9. PubMed ID: 11715443
[TBL] [Abstract][Full Text] [Related]
33. Hot-spot mutations in hepatitis B virus core gene: eliciting or evading immune clearance?
Liu Z; Luo K; He H; Hou J
J Viral Hepat; 2005 Mar; 12(2):146-53. PubMed ID: 15720529
[TBL] [Abstract][Full Text] [Related]
34. Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies.
Pushko P; Sallberg M; Borisova G; Ruden U; Bichko V; Wahren B; Pumpens P; Magnius L
Virology; 1994 Aug; 202(2):912-20. PubMed ID: 8030252
[TBL] [Abstract][Full Text] [Related]
35. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
36. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response.
Ishikawa T; Kakumu S; Yoshioka K; Yamada M; Tanaka K; Higashi Y; Takayanagi M; Okumura A; Kojima A; Tamura T
Immunology; 1993 Oct; 80(2):313-8. PubMed ID: 8262560
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B core antigen-specific IFN-gamma production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
Inoue M; Kakumu S; Yoshioka K; Tsutsumi Y; Wakita T; Arao M
J Immunol; 1989 Jun; 142(11):4006-11. PubMed ID: 2469730
[TBL] [Abstract][Full Text] [Related]
38. Multivalent DNA-based immunization against hepatitis B virus with plasmids encoding surface and core antigens.
Musacchio A; Rodriguez EG; Herrera AM; Quintana D; Muzio V
Biochem Biophys Res Commun; 2001 Mar; 282(2):442-6. PubMed ID: 11401479
[TBL] [Abstract][Full Text] [Related]
39. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
40. [Common linear B-cell epitopes in human hepatitis B virus core protein and woodchuck hepatitis virus core protein].
Zhang ZH; Wang R; Tian YJ; Li L; Xia JB; Gong JS; Lu MJ; Gong FL; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):605-8. PubMed ID: 17711632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
